Screener
Amneal Pharmaceuticals, Inc. AMRX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $69.61M+95.5% | $78M+217% | $49.57M+339% | $18.13M+54.2% | $35.61M+112% | ||
| $10.39M+25.6% | $8.82M+21.5% | $8.2M+13.8% | $8.22M+15.6% | $8.27M+23.1% | ||
| -$21.24M-125% | -$26.74M-461% | $130.32M+10.4% | $118.45M-16.5% | $83.82M+111% | ||
| $30.7M+34.5% | $8.18M-37.9% | $21.77M+43.7% | $12.3M-27.4% | $22.83M+115% | ||
| -$122.74M-362% | -$21.71M-22.0% | -$45.45M-183% | -$22.46M-8.5% | -$26.55M-311% | ||
| —— | $134.67M— | $2.48B+5,260% | $218M— | $0— | ||
| $79.36M+290% | -$59.06M-50.8% | -$10.12M+83.5% | —— | -$41.69M-18.8% | ||
| -$64.79M-524% | -$108.53M-117% | $74.53M+86.0% | $154.74M+439% | $15.28M+866% | ||
| -$51.94M-185% | -$34.92M-507% | $108.54M+5.5% | $106.15M-15.0% | $60.99M+110% |
FAQ
- How much cash does Amneal Pharmaceuticals, Inc. generate?
- Amneal Pharmaceuticals, Inc. (AMRX) generated $200.8M in operating cash flow over the trailing twelve months.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow?
- After $72.9M of capital expenditures, Amneal Pharmaceuticals, Inc.'s free cash flow was $127.8M over the trailing twelve months, down 54.8% year over year.
- Where does Amneal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
